Kamal, Swatabdi R.
Potukutchi, Shreya
Gelovani, David J.
Bonomi, Robin E.
Kallakuri, Srinivasu
Cavanaugh, John M.
Mangner, Thomas
Conti, Alana
Liu, Ren-Shyan
Pasqualini, Renata
Arap, Wadih
Sidman, Richard L.
Perrine, Shane A.
Gelovani, Juri G. http://orcid.org/0000-0002-8413-6161
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01DA042057)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA022453)
Article History
Received: 9 May 2021
Revised: 28 September 2021
Accepted: 15 October 2021
First Online: 14 January 2022
Competing interests
: RB and JGG are inventors on issued patents and pending patent applications related to PET imaging of HDACs class IIa expression-activity and are entitled to royalties if licensing or commercialization occurs. Potential conflicts of interest are managed in accordance with established institutional conflict of interest policies of the Wayne State University (Detroit, MI). The other authors declare that no conflicts of interest exist.